Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dymista Onset of Action in Seasonal Allergic Rhinitis
NCT04652245Phase 4Completed
- Sponsor
- Meda
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Meda. Primary endpoint: Change in Patient-assessed Instantaneous Total Nasal Symptom Score. Started Dec 2020; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT04652245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652245.